Company intelligence / Profile preview

Concord Laboratories

Ahmedabad, Gujarat, India

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Concord Biotech is a global leader in fermentation-based APIs, immunosuppressants, oncology drugs, and finished pharmaceutical formulations, operating three state-of-the-art manufacturing facilities, and distributing to over 70 countries. The company holds >20% market share in select APIs and has expanded product lines through continuous R&D and international regulatory approvals.

Therapeutic areas: ImmunologyNephrologyInfectious DiseasesOtherOncology
Modalities: Small moleculeBiologicMonoclonal antibodyRecombinant proteinSemi-synthetic small moleculeFermentation-based productPeptides
Industry: Biotech

Beyond the preview

Go deeper on Concord Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concord Laboratories.

Explore the full profile